NewsRoom Articles - CannabisNewsWire

MondayJul 27, 2026 4:20 pm

420 with CNW — Oklahoma Grapples with Inconsistent Marijuana Testing Standards, Lab Shopping

Oklahoma’s medical cannabis industry is facing renewed scrutiny as concerns over varying laboratory findings fuel debate about product safety and the effectiveness of current oversight. For Oklahoma patient Summer Parker, those concerns became deeply personal. She recalled experiencing severe episodes after smoking pre-rolls from Graves Farm Organics. According to Parker, she struggled to think clearly, had difficulty speaking, collapsed, and eventually required emergency medical assistance. At first, she did not suspect the cannabis product. However, after similar incidents repeatedly followed the use of the same brand, she and her spouse, Charles Hrabina, decided to have several products independently analyzed. Their lawsuit against the business alleges that testing revealed multiple pesticide failures, one microbial contamination issue, and…

MondayJul 27, 2026 4:20 pm

420 with CNW — Report Shows More Nebraskans Favor Marijuana Legalization

Support for marijuana legalization continues to grow across Nebraska, according to newly released survey findings, nearly two years after voters strongly backed the legalization of medical marijuana. The latest Nebraska Annual Social Indicators Survey, conducted by the University of Nebraska-Lincoln’s Rural Drug Addiction Research Center, compared public attitudes and cannabis use between 2024 and 2026. In the 2026 survey, 47% of Nebraskans said they favored allowing cannabis for both recreational and medical purposes, up from 44% in 2024. Backing for medical marijuana alone also rose during the same period, with 84% expressing support compared with 80% two years earlier. Nebraska residents approved medical cannabis through a statewide…

FridayJul 24, 2026 4:20 pm

420 with CNW — Key Questions Employers Need to Ask as Marijuana Laws Evolve

As cannabis laws continue to change across the U.S., employers are facing new challenges when it comes to workplace drug policies. Growing acceptance of cannabis use, combined with increasing rates of positive drug tests, is prompting many organizations to reconsider long-standing hiring and safety practices. Recent federal action has added another layer of complexity. Certain medical cannabis products have already been moved to Schedule III under federal law, while broader changes remain under review. If additional reforms move forward, businesses could see more requests for workplace accommodations as well as an increase in disability-related claims tied to cannabis use. Against this changing legal landscape, employers are trying to strike…

ThursdayJul 23, 2026 4:20 pm

420 with CNW — California Judge Signals Lawmakers May Not Need Voter Approval to Change Marijuana Regulations

A California judge has indicated that state lawmakers may have the authority to revise parts of the voter-approved marijuana legalization measure without asking voters to approve every legislative update. The preliminary opinion was issued last Thursday by San Francisco Superior Court Judge Harold Kahn during an ongoing legal dispute over changes to cannabis tax policy. The case was filed by youth advocacy organizations challenging legislation approved by the California Legislature and signed by Governor Gavin Newsom last year. The lawsuit seeks to overturn a reduction in the state’s cannabis retail excise tax, arguing that lawmakers exceeded their constitutional authority when they altered provisions tied to the 2016 legalization initiative. According to state figures,…

WednesdayJul 22, 2026 4:20 pm

420 with CNW — Senate Democrats Introduce Bill to Legalize Marijuana Federally

A group of Senate Democrats has renewed its push to remove marijuana from the federal list of controlled substances, taking a broader approach than the Trump administration’s ongoing effort to reclassify marijuana as a Schedule III drug. On July 16, 17 Democratic senators reintroduced the Cannabis Administration and Opportunity Act (CAOA), a proposal that would eliminate the federal ban on marijuana while creating a nationwide framework for regulation, taxation, and oversight. Originally introduced in 2021 and later revived in 2024, the legislation seeks to replace prohibition with a system similar to those governing alcohol and tobacco. The measure is being…

TuesdayJul 21, 2026 4:20 pm

420 with CNW — Idaho MMJ Initiative Fails to Qualify for November Ballot

Idaho voters will not have the opportunity to decide on a proposed medical cannabis measure during the upcoming November election after state officials ruled that the initiative failed to satisfy legal qualification standards. The decision was announced by the Idaho Secretary of State’s Office, which determined that the proposed Idaho Medical Cannabis Act Initiative didn’t collect enough valid support to earn a place on the statewide ballot. According to a letter sent to the Natural Medicine Alliance of Idaho (NMAI), the organization leading the campaign, the petition effort failed to meet several statutory requirements established under Idaho election law. To qualify for the ballot, supporters were required to collect signatures from at least 6% of registered voters in 18…

MondayJul 20, 2026 10:00 am

420 with CNW — Marijuana Alleviates Agitation in Nearly All Elderly Dementia Patients

A capsule containing a medically prepared cannabis oil has shown encouraging results in reducing agitation among older adults with dementia, offering fresh hope for families dealing with one of the condition's most difficult symptoms. Researchers reported that a formulated combination of purified THC and CBD, two compounds derived from cannabis, was linked to noticeable improvements in patients experiencing agitation during the later stages of dementia. The findings came from the Life’s End Benefits of cannabidiol and tetrahydrocannabinol (LiBBY) trial. The clinical study involved 120 people diagnosed with Alzheimer’s disease or other forms of dementia. After 12 weeks of treatment, almost nine out of 10 participants experienced an overall improvement,…

FridayJul 17, 2026 4:20 pm

420 with CNW — Congress Advances Bill Requiring Tracking Marijuana Tests in ERs

A House committee has moved forward with legislation directing the Department of Health and Human Services to examine how often hospital emergency units screen overdose patients for fentanyl, marijuana, and several other controlled substances. The proposal, introduced by Representative Ted Lieu, is known as Tyler’s Law. It honors 19-year-old Tyler Shamash, who died in 2018 after ingesting fentanyl. He was never tested for the synthetic opioid after arriving at a hospital with what was believed to be an overdose. The bill would require the HHS secretary to complete a nationwide review within one year if it becomes law. The research would evaluate how frequently emergency departments conduct fentanyl screenings alongside standard toxicology…

ThursdayJul 16, 2026 4:20 pm

420 with CNW — Banking Reform is Unlikely to Fix Marijuana Industry Payment Processing Challenges

For finance teams in the cannabis industry, managing payments often means navigating a complicated and uncertain system. Invoices are issued to retail customers, payment deadlines stretch out, and staff members juggle concerns over large electronic transfers, checks, cash deposits, and wire payments that have not fully cleared. At the same time, businesses must continue buying inventory, paying taxes, and maintaining banking relationships that can seem fragile. This challenge lies at the heart of wholesale cannabis payments. Public attention frequently focuses on cash transactions at dispensaries, yet the larger difficulties exist deeper in the supply chain. Growers, distributors, manufacturers, and operators with multiple locations regularly handle large-value transactions that…

WednesdayJul 15, 2026 4:20 pm

420 with CNW — Study Shows Restless Legs Syndrome Patients Benefit from Medical Marijuana

A new study suggests that marijuana-based treatment may provide lasting relief for people living with restless legs syndrome (RLS). RLS causes an overwhelming urge to move the legs and disrupts sleep. The disorder affects an estimated 7 to 12 percent of adults in North America and Europe and is more frequent among those with multiple sclerosis. For many years, dopamine agonists have been considered the primary therapy for RLS. More recently, however, research has shifted toward gabapentinoids as a preferred option. Since cannabinoids and gabapentinoids influence similar biological pathways involving certain amino acids linked to the condition, researchers wanted to determine whether cannabis compounds could also ease symptoms. The open-label study enrolled adults with long-term RLS whose symptoms had persisted despite…